Tacrolimus for the Treatment of Subepithelial Infiltrates Resistant to Topical Steroids After Adenoviral Keratoconjunctivitis

201433 citationsJournal Article

Authors

Topical 0.03% tacrolimus seemed to be an effective corticosteroid-sparing agent for the treatment of SEIs after AK.

Good health and well-being

Published in: Cornea

Volume 33, Issue 11, pp. 1210-1213

Field-Weighted Citation Impact: 2.16